AGAminda Figueroa Gonzalez

Aminda Figueroa Gonzalez

*This is an algorithmically generated author record based on publicly available information.

Aminda Figueroa Gonzalez has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Déficit de 17α-hidroxilasa en neonato simulando sepsis con injuria renal aguda: un desafío diagnóstico

    by Rosa Velastegui Murgueitio, Evelyn Suarez Coello, Aminda Figueroa Gonzalez

    Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder of adrenal steroidogenesis, most commonly caused by 21-hydroxylase deficiency. Rare variants, such as 17α-hydroxylase deficiency, present distinct clinical features and are seldom recognized in the neonatal period. We report the case of a term female neonate admitted at 17 days of life with severe dehydration secondary to gastrointestinal losses, associated with vomiting, metabolic acidosis, and acute kidney injury of prerenal origin. Physical examination revealed mild genital hyperpigmentation without virilization, raising suspicion of CAH. Laboratory evaluation showed elevated 17-hydroxyprogesterone levels (9.54 ng/mL), confirming the diagnosis. The patient was treated with intensive fluid resuscitation, metabolic correction, blood transfusion, and antibiotic therapy, with favorable clinical outcome and recovery of renal function. This case highlights an atypical neonatal presentation of CAH mimicking infectious or gastrointestinal conditions and underscores the importance of considering endocrine disorders in neonates with severe dehydration and metabolic disturbances.

  • Open Access

    Síndrome inflamatorio multisistémico neonatal asociado a SARS-CoV-2 con compromiso coronario: reporte de caso

    by Rosa Velastegui-Murgueitio, Evelyn Suarez-Coello, Aminda Figueroa-Gonzalez, Ricardo Abarracin-Cevallos

    Neonatal multisystem inflammatory syndrome (MIS-N) is an emerging condition associated with perinatal exposure to SARS-CoV-2 and characterized by a systemic hyperinflammatory response with multiorgan involvement. Although it is a rare condition, early recognition is essential due to the potential cardiovascular complications, which may manifest as myocardial dysfunction or coronary artery dilation. We report the case of a preterm male newborn delivered at 34 weeks of gestation with a birth weight of 1490 g, born to a mother with a history of respiratory illness compatible with COVID-19 during pregnancy. The infant was delivered by emergency cesarean section due to fetal distress and presented neonatal depression and respiratory distress syndrome requiring mechanical ventilation and surfactant administration. During his stay in the neonatal intensive care unit, he developed multisystem involvement characterized by severe thrombocytopenia, anemia, necrotizing enterocolitis, neonatal seizures, and grade II intraventricular hemorrhage. Echocardiography revealed dilation of both coronary arteries and mild pericardial effusion. Laboratory tests demonstrated elevated inflammatory and cardiac biomarkers, including troponin, NT-proBNP, ferritin, interleukin-6, and D-dimer. Based on the suspicion of MIS-N associated with SARS-CoV-2 exposure, treatment with intravenous immunoglobulin, methylprednisolone, and anticoagulation with enoxaparin was initiated, in addition to intensive neonatal support. The patient showed favorable clinical evolution with progressive normalization of inflammatory markers and resolution of coronary dilation on follow-up echocardiography. This case highlights the importance of considering MIS-N in neonates with multisystem involvement and elevated inflammatory markers in the context of perinatal exposure to SARS-CoV-2.

  • Open Access

    Impacto de la calidad del transporte en la estabilidad clínica neonatal: uso del TRIPS II

    by Gema Elizabeth Arteaga Vergara, Carolina Rocío Bello Vinueza, Aminda Karina Figueroa González, Sara María Maldonado Vivanco

    Introduction: Neonatal transport is a critical time for newborns requiring specialized care. The quality of this transport can significantly determine prognosis and survival. This study evaluated the quality of neonatal transport using the TRIPS II index to determine its impact on clinical stability and early mortality. Methodology: A prospective observational cohort-correlational study with longitudinal design was performed. We analyzed 130 newborns admitted to a national reference hospital between June and August 2024, transferred from type A (hospitals with limited resources) and type B (hospitals with complete resources) institutions. The TRIPS II index was used to assess physiological stability at admission and at 12 hours. Neonatal variables, transport factors and institutional resources were analyzed, calculating odds ratios (OR) with 95% confidence intervals. Results: Incomplete human and material resources showed significant inverse associations (OR: 3.03; 95% CI: 0.46-3.14). Variables such as weight ≤1500g (OR: 1.58; 95% CI: 0.495-5.038) and gestational age <30 weeks (OR: 1.8; 95% CI: 0.529-6.129) lost statistical significance after 12 hours in the NICU. Neonates with TRIPS II score ≥20 at admission had a higher risk of mortality (OR: 2.08), increasing significantly when this score persisted at 12 hours (OR: 7.81). Type A institutions presented significantly higher TRIPS II scores at admission (20.87±11.32 vs. 14.23±9.43 in type B). Conclusions: The TRIPS II index is an effective predictor of neonatal mortality, especially when high scores persist after 12 hours of admission. The availability of human and material resources during transport significantly influences the clinical stability of the neonate.